THE PDGFRA-REGULATING LNCRNA LINC02283 IS AMPLIFIED IN HIGH-GRADE GLIOMA AND FACILITATES GLIOMAGENESIS

被引:0
|
作者
Goenka, Anshika [1 ]
Song, Xiao [2 ]
Tiek, Deanna [1 ]
Hu, Bo [1 ]
Cheng, Shi-Yuan [2 ]
机构
[1] Northwestern Univ, Chicago, IL USA
[2] Northwestern Univ, Lou & Jean Malnati Brain Tumor Inst, Simpson Querrey Inst Epigenet,Robert H Lurie Comp, Ken & Ruth Davee Dept Neurol,Feinberg Sch Med, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CSIG-14
引用
收藏
页码:41 / 42
页数:2
相关论文
共 20 条
  • [1] The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
    Huse, Jason T.
    Brennan, Cameron
    Hambardzumyan, Dolores
    Wee, Boyoung
    Pena, John
    Rouhanifard, Sara H.
    Sohn-Lee, Cherin
    le Sage, Carlos
    Agami, Reuven
    Tuschl, Thomas
    Holland, Eric C.
    GENES & DEVELOPMENT, 2009, 23 (11) : 1327 - 1337
  • [2] The PTEN-Regulating MicroRNA miR-26a is Amplified in High-Grade Glioma and Facilitates Gliomagenesis in vivo
    Huse, Jason
    Brennan, Cameron
    Hambardzumyan, Dolores
    Pena, John
    Rouhanifard, Sara
    Sohn-Lee, Cherin
    le Sage, Carlos
    Agami, Reuven
    Tuschl, Thomas
    Holland, Eric
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 558 - 558
  • [3] Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma
    Koschmann, Carl
    Zamler, Daniel
    MacKay, Alan
    Robinson, Dan
    Wu, Yi-Mi
    Doherty, Robert
    Marini, Bernard
    Tran, Dustin
    Garton, Hugh
    Muraszko, Karin
    Robertson, Patricia
    Leonard, Marcia
    Zhao, Lili
    Bixby, Dale
    Peterson, Luke
    Camelo-Piragua, Sandra
    Jones, Chris
    Mody, Rajen
    Lowenstein, Pedro R.
    Castro, Maria G.
    ONCOTARGET, 2016, 7 (40) : 65696 - 65706
  • [4] CHARACTERIZING AND TARGETING PDGFRA ALTERATIONS IN PEDIATRIC HIGH-GRADE GLIOMA
    Koschmann, Carl
    Zamler, Dan
    MacKay, Alan
    Robinson, Dan
    Wu, Yi-Mi
    Doherty, Robert
    Marini, Bernard
    Tran, Dustin
    Garton, Hugh
    Muraszko, Karin
    Robertson, Patricia
    Leonard, Marcia
    Zhao, Lili
    Bixby, Dale
    Peterson, Luke
    Camelo-Piragua, Sandra
    Jones, Chris
    Mody, Rajen
    Lowenstein, Pedro R.
    Castro, Maria G.
    NEURO-ONCOLOGY, 2016, 18 : 75 - 75
  • [5] CONTRASTING CLINICAL COURSES OF THREE PEDIATRIC PATIENTS WITH PDGFRA AMPLIFIED RADIATION-INDUCED HIGH-GRADE GLIOMA
    Greenwell, Alyssa M.
    Bhambhani, Kanta
    Toll, Stephanie
    Kupsky, William
    Altinok, Deniz
    Gorsi, Hamza S.
    NEURO-ONCOLOGY, 2024, 26
  • [6] TRANSLATION OF THE PDGFRA/KIT INHIBITOR AVAPRITINIB FOR PEDIATRIC HIGH-GRADE GLIOMA
    Mayr, Lisa
    Trissal, Maria
    Schwark, Kallen
    Labelle, Jenna
    Kong, Seongbae
    Groves, Andrew
    Supko, Jeffrey
    Hack, Olivia
    Marques, Joana
    Panditharatna, Eshini
    Dubois, Frank
    Greenwald, Noah
    Bandopadhayay, Pratiti
    Ligon, Keith
    Furtner-Srajer, Julia
    Weiler-Wichtl, Liesa
    Leiss, Ulrike
    Rosenmayr, Verena
    Madlener, Sibylle
    Stepien, Natalia
    Lotsch-Gojo, Daniela
    Dorfer, Christian
    Dieckmann, Karin
    Azizi, Amedeo
    Guntner, Armin
    Palova, Hana
    Slaby, Ondrej
    Pokorna, Petra
    Beroukhim, Rameen
    Kramm, Christof
    Jones, David T.
    Sterba, Jaroslav
    Mullauer, Leonhard
    Haberler, Christine
    Perez, Nisha
    Kim, Sean
    Hsieh, Anthony
    Dimitrijevic, Sasa
    Skrypek, Mary
    Martinez, Nina
    Bowers, Daniel
    Filbin, Mariella
    Gojo, Johannes
    Koschmann, Carl
    NEURO-ONCOLOGY, 2022, 24 : 103 - 103
  • [7] INTRANASAL DELIVERY OF PDGFRA-TARGETED NANOTHERAPEUTICS FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMA
    Mineji, Kentaro
    Watanabe, Jun
    Uchida, Eita
    Kaur, Savneet
    Zhang, Peng
    Hashizume, Rintaro
    NEURO-ONCOLOGY, 2024, 26
  • [8] CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS
    Mayr, Lisa
    Trissal, Maria
    Schwark, Kallen
    Neyazi, Sina
    Beck, Alexander
    Labelle, Jenna
    Marques, Joana Graca
    Weiler-Wichtl, Liesa
    Madlener, Sibylle
    Kong, Seongbae
    Miclea, Madeline
    Supko, Jeffrey
    Guntner, Armin Sebastian
    Palova, Hana
    Neradil, Jakub
    Stepien, Natalia
    Loetsch-Gojo, Daniela
    Dorfer, Christian
    Dieckmann, Karen
    Peyrl, Andreas
    Azizi, Amedeo A.
    Baumgartner, Alicia-Christina
    Slaby, Ondrej
    Pokorna, Petra
    Dubois, Frank
    Greenwald, Noah
    Bandopadhayay, Pratiti
    Beroukhim, Rameen
    Ligon, Keith
    Kramm, Christof
    Bronsema, Annika
    Bailey, Simon
    Stuecklin, Ana Guerreiro
    Mueller, Sabine
    Skrypek, Mary
    Martinez, Nina
    Bowers, Daniel C.
    Jones, David
    Jones, Chris
    Jaeger, Natalie
    Sterba, Jaroslav
    Muellauer, Leonhard
    Haberler, Christine
    Kumar-Sinha, Chandan
    Chinnaiyan, Arul
    Mody, Rajen
    Furtner-Srajer, Julia
    Koschmann, Carl
    Gojo, Johannes
    Filbin, Mariella
    NEURO-ONCOLOGY, 2023, 25
  • [9] Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma
    Li, Xinqiao
    Xu, Jingcheng
    Li, Xue
    Shi, Jianghua
    Wei, Chunmi
    Liang, Qingyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma
    Wang, Wen
    Wu, Fan
    Zhao, Zheng
    Wang, Kuan-Yu
    Huang, Ruo-Yu
    Wang, Hao-Yuan
    Lan, Qing
    Wang, Jiang-Fei
    Zhao, Ji-Zong
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (10) : 957 - 966